Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
04/2007
04/03/2007US7199167 Formed from mesogen such as 2,7-bis{5-[4-(8-diallylaminooctyloxy)phenyl]-thien-2-yl}-9,9-dipropylfluorene; photopolymerization without photoinitiator; lowcost, bright, portable displays; simple manufacturing, enhanced power and transmission efficiency; does not require polarizer
04/03/2007US7199150 Amino alcohol compounds
04/03/2007CA2163174C Hindered aromatic ester compounds useful as anti-viral agents
03/2007
03/29/2007WO2007016115A3 6,13-bis(thienyl)pentacene compounds
03/29/2007WO2007015809A3 Hiv reverse transcriptase inhibitors
03/29/2007WO2007010085A3 New pharmaceutical compounds
03/29/2007WO2007010085A2 New pharmaceutical compounds
03/29/2007WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/29/2007WO2006136135A3 Method for decarboxylating c-c cross-linking of carboxylic acids with carbon electrophiles
03/29/2007WO2006078287A3 Pde4b inhibitors and uses therefor
03/29/2007WO2005112640A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
03/28/2007EP1767608A1 Tris(thienylphenyl)amine derivatives as organic semiconductors
03/28/2007EP1765886A1 Metallocene compounds, ligands used in their preparation, preparation of 1-butene polymers and 1-butene polymers therefrom
03/28/2007EP1765814A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists
03/28/2007EP1765803A1 Quaternary salt ccr2 antagonists
03/28/2007CN1938320A Compounds and methods for treating dyslipidemia
03/28/2007CN1938298A Methods for minimizing thioamide impurities
03/28/2007CN1935808A Long-Chain aromatic piperazine modified duloxetine-like compound, and its preparation and use
03/28/2007CN1935797A Novel bichalcophenes and their prodrugs as antiprotozoal agents
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1307156C Polyarylcarboxamides useful as lipid lowering agents
03/27/2007USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations
03/27/2007US7196207 Hydrogenating a 2-alkylene-3-amidothiophene using a noble metal catalyst, paladium-carbon, and controlled heating of 150-300 degrees C. to obtain a 2-alkyl-3-aminothiophene; recovering/reuseing the catalyst; catalyst selectivity; efficiency; industrial scale;bactericides/intermediates;agriculture; drugs
03/27/2007US7196206 Asymmetrical linear organic oligomers
03/27/2007US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis
03/27/2007US7196114 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/27/2007US7196106 Cyanothiophene derivatives, compositions containing such compounds and methods of use
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains
03/27/2007CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
03/22/2007WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c
03/22/2007WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto
03/22/2007WO2006117609A3 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
03/22/2007WO2006078574A3 Mitotic kinesin inhibitors
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066680 Benzofurans and benzothiophenes
03/22/2007US20070066675 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
03/22/2007US20070066667 Novel thiophene sulfoximines, compositions thereof, and methods treating complement-mediated diseases and conditions
03/22/2007US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/22/2007US20070066595 Selective estrogen receptor modulators
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/22/2007US20070063189 Compounds based on fluoranthene and use thereof
03/22/2007CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c
03/21/2007EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity
03/21/2007EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity
03/21/2007EP1763511A1 Phenoxyacetic acid derivatives as ppar agonists
03/21/2007EP1763502A1 Novel hexafluoroisopropanol derivatives
03/21/2007EP1578740B1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system
03/21/2007EP1313729B1 Design and synthesis of thiophene derived nlo materials for electro-optic applications
03/21/2007EP1020456B1 Polyhydric phenols, epoxy resins, epoxy resin composition, and cured products thereof
03/21/2007EP0817643B1 Compounds and compositions for delivering active agents
03/21/2007CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
03/21/2007CN1934078A Stereoselective synthesis of vitamin D analogues
03/21/2007CN1931839A Synthesis process of N-substituted pyrrole
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/21/2007CN1305852C Diaryl ethers as opioid receptor antagonist
03/21/2007CN1305846C Novel urea derivatives
03/20/2007US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007US7192965 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
03/20/2007US7192535 Conjugated molecule and electroluminescent device thereof and electronic device having the electroluminescent device
03/20/2007CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production
03/15/2007WO2007030366A1 Regioselective process for preparing benzimidazole thiophenes
03/15/2007WO2007029037A2 Class iia histone deacetylase (hdac) substrate
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007028337A1 Preparation of clopidogrel and its analogues methyl tetrahydrothienopyridine acetate compounds
03/15/2007WO2006110276A3 Acylated thiosemicarbazides as herbicides
03/15/2007WO2006094945A3 Method for producing optically active alcohols by means of enzymatic reduction
03/15/2007US20070060587 Indane derivates as muscarinic receptor agonists
03/15/2007US20070060480 Heteroaroyl-substituted phenylalanineamides
03/15/2007US20070057229 Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same
03/15/2007CA2621448A1 Class iia histone deacetylase (hdac) substrate
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
03/15/2007CA2621406A1 Pparactive compounds
03/15/2007CA2621073A1 Regioselective process for preparing benzimidazole thiophenes
03/14/2007EP1761571A1 Transition metal compound, ligand system., catalyst system and process for preparing polyolefins
03/14/2007EP1761486A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
03/14/2007CN1930172A Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
03/14/2007CN1927866A Preparation method of methyl thienotetrahydropyridinacetate
03/14/2007CN1927865A Synthesis method of thienotetrahydropyridine acetonitrile
03/14/2007CN1927864A Preparation method of thienotetrahydropyridinacetic acid and salt thereof
03/14/2007CN1927863A Preparation method of thienotetrahydropyridinacetic acid and salt thereof
03/14/2007CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals
03/14/2007CN1304360C Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine
03/13/2007US7189877 Arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices
03/13/2007US7189725 Administering (-)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol or a pharmaceutically acceptable salt thereof for reducing ischemic damage
03/08/2007WO2007027599A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
03/08/2007WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
03/08/2007US20070054956 6-(4-Methoxy-phenyl)-5-{4-[4-(4,4,5,5,5-pentafluoropentylsulfanyl/ pentafluoropentanesulfinyl)-butoxy]-phenoxy}-naphthalen-2-ol; anticarcinogenic agent; breast cancer, metastases to the bone or brain, radiation fibrosis and neutropenic sepsis
03/08/2007US20070054945 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 329